Activists File Patent Opposition to Challenge COVID-19 Drug Monopoly on Baricitinib
NewsActivists from Morocco, Thailand, and Vietnam have filed patent oppositions to challenge drug manufacturers Incyte and Eli Lilly over the...
Read more about Activists File Patent Opposition to Challenge COVID-19 Drug Monopoly on Baricitinib
-
MMA and ITPC’s 3rd POA: building capacity to challenge low quality patents
NewsThe Academies aim to provide practical training and capacity building for civil society groups and activists in challenging pharmaceutical patents...
Read more about MMA and ITPC’s 3rd POA: building capacity to challenge low quality patents
-
Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
Call to action News Press releaseThis week, civil society in Morocco has called for the urgent removal of unnecessary legal barriers, which are “tailor-made for...
Read more about Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
-
Moroccan civil society calls for compulsory licence on Gilead’s possible COVID-19 drug
NewsOn 12 May 2020, Gilead Sciences announced voluntary licenses to five generic manufacturers in India and Pakistan allowing them to...
-
Postponed: Global Summit on Intellectual Property and Access to Medicines
NewsThe 2020 summit will now take place at a later date, at a time when we are assured that international...
Read more about Postponed: Global Summit on Intellectual Property and Access to Medicines
-
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Call to action News ResearchDrugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...
-
Activists ask pharma corporations: “Is the Middle East and North Africa a priority?”
Call to action NewsA CAB meeting was held in Morocco, providing an opportunity to discuss access to treatment in a region facing an...
Read more about Activists ask pharma corporations: “Is the Middle East and North Africa a priority?”
-
ICASA 2019: “Civil society will not leave the MENA region behind”
Call to action NewsAt the 20th International Conference on AIDS and STIs in Africa (ICASA 2019), treatment advocates drew attention to the factors...
Read more about ICASA 2019: “Civil society will not leave the MENA region behind”
-
Fixing the broken patent system: From Marrakech and back again
NewsMarrakech was home to the signing of the TRIPS Agreement in 1995, an agreement that has been exploited by pharmaceutical...
Read more about Fixing the broken patent system: From Marrakech and back again
-
GSIPA2M: The Summit Highlights
NewsCatch up on the activity from our inaugural Global Summit on Intellectual Property and Access to Medicines (15-17 January 2018)....
